In March 2012, the College of American Pathologists and American Society for Colposcopy
and Cervical Pathology, in collaboration with 35 stakeholder organizations, convened a …

Abstract BACKGROUND The 1991 Bethesda System for cervical/vaginal cytology reporting
defined adequacy criteria for the unsatisfactory designation. Most laboratories have …

BACKGROUND The interpretation of atypical glandular cells (AGC) in Papanicolaou (Pap)
tests and screening for glandular neoplasia remain challenging. METHODS Pap tests with …

ContextEvery year approximately 2 million US women are diagnosed as having a cervical
cytological result of atypical squamous cells of undetermined significance (ASC-US) …

We sought to determine whether the variability in dysplasia rates in cases of atypical
squamous cells of undetermined significance (ASCUS) reflects variability in interpretation of …

Objective: We prospectively studied the diagnostic utility of our Bethesda system–based
cervical cytology screening program with colposcopy and biopsy as the criterion standard …

New data have emerged since publication of the American Society for Colposcopy and
Cervical Pathology's 2001 consensus guidelines for management of abnormal cervical …

There are many different systems of cytology classification used in the member states of the
European Union (EU) and many different languages. The following short annexe to Chapter …

Statistics and methods for the validation of the results of cytologic screening for cervical
cancer and its precursors were examined. Many of the methods commonly used, including …

The current paper presents the first part of Chapter 6 of the second edition of the European
Guidelines for Quality Assurance in Cervical Cancer Screening. It provides guidance on how …